Hims & Hers shares jump as Trump's FDA pick seen as major ally

Hims & Hers shares jump as Trump's FDA pick seen as major ally

Hims & Hers Health Inc. stock surged on news of potential FDA leadership changes. The company may benefit from this with a positive outlook, despite facing challenges with their GLP-1 drugs. Analysts are cautious, with varied opinions on the stock.

Read More

Did you find this insightful?